Stay updated on Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page
- Check4 days agoChange DetectedAdded Contacts/Locations and Study Status sections to the record (update on 2026-03-31; version 76), replacing the previous 2026-03-16 entry.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded Contacts/Locations and Study Status sections. Updated the revision from v3.4.3 to v3.5.0 on 2026-03-16.SummaryDifference0.3%

- Check26 days agoChange DetectedAdded Contacts/Locations and Study Status in revision v3.4.3. The previous v3.4.2 was superseded.SummaryDifference0.3%

- Check33 days agoChange DetectedAdded Contacts/Locations and Study Status sections on 2026-02-27; deletion on 2026-02-18 removed content.SummaryDifference0.2%

- Check40 days agoChange DetectedNew Contacts/Locations and Study Status entries were added in the 2026-02-18 update, and the 2026-02-09 entry was removed.SummaryDifference0.2%

- Check54 days agoChange DetectedVersion 71 (2026-02-06) added Contacts/Locations and updated Study Status, with Revision: v3.4.2. The funding-notice banner from 2026-01-20 was removed.SummaryDifference0.6%

Stay in the know with updates to Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.